Exicure’s Collaboration, Option and License Agreement with Allergan

Fenwick & West advised Exicure, Inc. on the deal. Exicure, Inc. (NASDAQ:XCUR) and Allergan’s wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, have entered into a global collaboration…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now